Literature DB >> 2875889

Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine.

H S Ahn, A Barnett.   

Abstract

Displacement of [3H]mepyramine binding was compared in membranes from guinea-pig lung vs. cerebral cortex as a measure of affinity for peripheral vs. central nervous system (CNS) histamine receptors. Loratadine, a new non-sedating antihistamine, was found to be the only compound tested which was selective for lung (Ki = 35 nM) vs. cortex (Ki = 118 nM). This difference is statistically significant (P less than 0.05) whereas there was no significant (P greater than 0.05) difference in the Kis between the 2 tissues for terfenadine, astemizole, mequitazine or chlorpheniramine. It is concluded from these and other studies that the lack of significant sedative effects shown with loratadine is due to its poor penetration into the CNS and selectivity for peripheral histamine receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875889     DOI: 10.1016/0014-2999(86)90219-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Influence of certain H1-blockers on the step-through active avoidance response in rats.

Authors:  C Kamei; Y H Chung; K Tasaka
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Rocastine (AHR-11325), a rapid acting, nonsedating antihistamine.

Authors:  J C Nolan; D J Stephens; A G Proakis; C A Leonard; D N Johnson; B F Kilpatrick; M H Foxwell; J M Yanni
Journal:  Agents Actions       Date:  1989-08

4.  Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene.

Authors:  A N Nicholson; P A Pascoe; C Turner; C R Ganellin; P M Greengrass; A F Casy; A D Mercer
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

5.  Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.

Authors:  Mazen El-Hammadi; Nisrine Awad
Journal:  AAPS PharmSciTech       Date:  2011-11-19       Impact factor: 3.246

Review 6.  Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis.

Authors:  Leonard Bielory; Kenneth W Lien; Steve Bigelsen
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Modulation by histamine of the delayed outward potassium current in guinea-pig ventricular myocytes.

Authors:  K Yazawa; Y Abiko
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  The in vivo and in vitro activity of AHR-13268D, a new antiallergic/antihistaminic agent.

Authors:  J C Nolan; M H Foxwell; L L Whitman; D N Johnson; J M Yanni; S V Greene
Journal:  Agents Actions       Date:  1990-11

Review 9.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 10.  Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  S P Clissold; E M Sorkin; K L Goa
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.